At its booth at the Society of Nuclear Medicine meeting, nuclear medicine vendor SMV will feature images from recent clinical studies under way to validate new technologies ranging from artifact correction to high-energy coincidence detection imaging.In
At its booth at the Society of Nuclear Medicine meeting, nuclear medicine vendor SMV will feature images from recent clinical studies under way to validate new technologies ranging from artifact correction to high-energy coincidence detection imaging.
In cardiac imaging, the Twinsburg, OH, company will display the latest studies from its Transmission Attenuation Correction (TAC) sites. The sites are demonstrating the value of using TAC on its own and in conjunction with SMV's Stasis motion correction algorithm and Restore depth-dependent resolution recovery technique.
In the coincidence detection realm, SMV will show images from its Volumetric Coincidence Reconstruction (VCR) option, which received 510(k) clearance in March for the Vision FX-80 fixed 180 dual-head camera (SCAN 4/16/97). SMV is waiting for clearance of VCR for its variable-angle cameras, according to Bill Bishop, vice president of business development. SMV will emphasize VCR image quality enhancements with algorithms such as randoms correction.
On the workstation side, the PowerStation SPX and MPX computers will be displayed, with SMV's new Vision 4.1 software. The software includes increased protocol automation, better edge detection, and the addition of Transient Ischemic Dilitation (TID) to SMV's MultiDim 3-D quantification.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.